1. Home
  2. EYE vs QURE Comparison

EYE vs QURE Comparison

Compare EYE & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$27.29

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$22.52

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYE
QURE
Founded
1990
1998
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2017
2007

Fundamental Metrics

Financial Performance
Metric
EYE
QURE
Price
$27.29
$22.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
12
Target Price
$29.00
$58.55
AVG Volume (30 Days)
1.2M
2.0M
Earning Date
02-25-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,921,355,000.00
$15,751,000.00
Revenue This Year
$9.58
N/A
Revenue Next Year
$4.90
$142.93
P/E Ratio
N/A
N/A
Revenue Growth
6.33
N/A
52 Week Low
$10.45
$7.76
52 Week High
$30.02
$71.50

Technical Indicators

Market Signals
Indicator
EYE
QURE
Relative Strength Index (RSI) 48.27 43.74
Support Level $25.61 $21.15
Resistance Level $30.02 $23.34
Average True Range (ATR) 1.20 1.59
MACD 0.11 0.22
Stochastic Oscillator 37.98 17.91

Price Performance

Historical Comparison
EYE
QURE

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: